Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Funding in focus for WntResearch

The cancer therapy company WntResearch entered 2023 with a strengthened cash position after a successful share issue that provided approximately 26.5 MSEK. Recently, the company also announced that warrants of series TO5 were exercised to approximately 92.2 per cent. This adds another 10.6 MSEK to the company. BioStock spoke to CEO Pernilla Sandwall to find out more about the latest quarter and the way forward for the company.Read the full article at biostock.se : https://www.biostock.se/en/2023/05/funding-in-focus-for-wntresearch/ This is a press release

Carbiotix signs agreement with top 10 global probiotics company

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company has signed an agreement with a top 10 global probiotics company for the development of synbiotics utilizing Carbiotix prebiotic nutraceutical ingredients. This is Carbiotix’s first customer development agreement with a leading global probiotic consumer product company and will last at least until the second half of 2024 with each party covering their own costs. Given the growing global interest in synbiotics (ie. combining prebiotics and probiotics), this agreement has the potential to increase Carbiotix’s total

TactoTek® receives ISO 14001 Environmental Management System (EMS) Certification

· TactoTek’s Environmental Management System (EMS), used to manage IMSE® technology’s sustainability initiatives, receives ISO 14001 certification · ISO 14001 sets out the criteria for implementing an effective environmental management system and guides companies in identifying, managing, and controlling their environmental impacts · Sustainability is inherent in IMSE technology, providing TactoTek and its Licensees the ability to affect product sustainability throughout the complete life cycle - from design to recyclingOulu, Finland (10 May 2023) – TactoTek® 

Finnish authority orders Sectra Tiger solution for mobile communication of classified information

Linköping – May 10, 2023 – A Finnish authority has ordered units of the approved high assurance mobile encryption solution Sectra Tiger/S from international cybersecurity and medical imaging IT company Sectra  (STO: SECT B). The solution enables users to securely and efficiently communicate classified information up to and including the classification level SECRET—information that could, if it were to fall into the wrong hands, severely damage the security of a nation or its allies.“It is crucial for us to always be able to communicate classified information, regardless

The subscription period in Brain+ rights issue begins today

COMPANY ANNOUNCEMENT Copenhagen, Denmark, May 10, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASUREToday, 10 May 2023, the subscription period commences in Brain+ A/S (“Brain+” or the “Company”) issue of units with pre-emptive

Peptonic signs license agreement with Prima Lab regarding self-test for urinary tract infections

PEPTONIC Medical AB announces that the company has signed a license agreement with Swiss medical technology company Prima Lab SA regarding self-tests for urinary tract infections for sale in Sweden.The agreement means that Peptonic gets the right to sell Prima Lab's self-test for urinary tract infections under its own brand VagiVital[®] in Sweden, with a planned launch at the end of 2023. "Urinary tract infections affect 40% of all women of all ages at some point in their lives, with many experiencing recurrent infections. Adding another high-quality self-test to the reference market

Embassy of Sweden in India now verified on Truecaller to enable secure communication for users

The Embassy of Sweden in India has joined hands with Truecaller, the world’s leading global communications platform, to make communication with users safer and more reliable. As a part of this collaboration, Truecaller’s Business Identity solutions has registered the Embassy as a Verified Business, and will display all incoming calls from the Embassy with a verified blue tick mark and logo.Amid the rising number of visa application scams across the country, the partnership reaffirms the shared dedication of The Embassy of Sweden and Truecaller to provide citizens with secure and dependable

Interim Financial Report Q1 2023: Challenging start to the year as expected

Company Announcement No. 536, 2023CHIEF EXECUTIVE OFFICER JÖRG BRINKMANN QUOTE “As expected, it was a challenging start to the year with very low newbuild activities across our markets. In response to the current market environment, we have adjusted our shift patterns and have also decided to accelerate the optimisation of our factory network, which will involve closing three factories in Germany and two in Poland. Following recent investments in our factories, we have sufficient capacity for both present and future needs, which puts us in a favourable position for when the market

Brain+ closes its second sales contract for CST – Therapist Companion with a dementia care center in Gladsaxe municipality

Copenhagen, Denmark, May 10, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Gladsaxe is the second Danish municipality to have opened for use of CST – Therapist Companion to support Cognitive Stimulation Therapy (CST) for people with dementia · Two contract closings less than 6 months after CST - Therapist Companion was commercially introduced is promising, considering a typical municipal sales cycle of 12-24 months · Denmark is an important reference market for Brain+ with CST gaining widespread recognitionBrain+ announces to have closed a second sales contract for the company’

Correction: Nordic Mining ASA (EN Expand:NOM): Interim report per 31 March 2023

Reference is made to the stock exchange notice from Nordic Mining ASA (the "Company") earlier today regarding the interim report per 31 March 2023. Please find enclosed Nordic Mining’s company presentation for the first quarter of 2023. Oslo, 10 May 2023Nordic Mining ASA Nordic Mining ASA (www.nordicmining.com) Nordic Mining ASA (“Nordic Mining” or the “Company”) is a resource company with focus on high-end industrial minerals and metals. The Company’s project portfolio is of high international standard and holds significant economic potential. The Company’s assets are in the

Asetek A/S – Final results of the Rights Issue

Aalborg, 10 May 2023. NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Reference is made to the stock exchange announcement by Asetek A/S (the "Company" or "Asetek") on 8 May 2023 regarding the preliminary results of the fully underwritten rights issue of 71,166,667 new shares in the Company (the "New Shares") at a subscription price of NOK 3 per share, raising gross proceeds of NOK 213,500,001, equivalent to approximately DKK

BioStock: Janssen CAR T deal supports Elicera’s vision

The 245 million USD deal between Janssen and Cellular Biomedicine Group to develop next generation CAR T therapies signals a strong willingness to invest in the field. The deal raises commercial hopes for other players in the CAR T space. One of these is Elicera Therapeutics, whose candidate, ELC-301, also targets the CD20 antigen for the treatment of Non-Hodgkin's Lymphoma.Read the article at biostock.se: Janssen CAR T deal supports Elicera’s vision - BioStock This is a press release from BioStock -

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for April 2023

Oslo, Norway, May 10, 2023 Commercial update: In April 2023, the Company achieved average time charter equivalent earnings of approximately US$24,400 per day, gross. The Company’s five vessels trading on index-linked time charter earned approximately US$26,100 per day, gross, including average daily scrubber benefits of approximately US$4,100 per day. The Company’s three vessels trading on fixed time charter earned approximately US$21,600 per day, gross, including scrubber benefits. The Baltic 5TC Capesize Index averaged US$15,931 during April 2023. Cash Distribution: The

Invitation to presentation of Catena Media’s Q1 results 2023

Catena Media’s interim report for the first quarter that ended 31 March 2023 will be published in English on Wednesday 17 May at 07:00 CEST. Following the report’s release, a combined presentation audiocast and telephone conference with the opportunity to ask questions will be held at 09:00 CEST on the same day, with CEO Michael Daly and Group CFO Peter Messner presenting the report. WebcastVia the webcast you are able to ask written questions. If you wish to participate via webcast, please use the following link: https://ir.financialhearings.com/catena-media-q1-2023

UNION therapeutics to present at 4th Annual Dermatology Drug Development Summit Europe

Hellerup, Denmark, May 10, 2023 – UNION therapeutics A/S (UNION), a privately held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, today announced that Dr. Kim D. Kjøller, CEO of UNION therapeutics will present at the seminar on hidradenitis suppurativa (HS) at the 4th Annual Dermatology Drug Development Summit Europe on May 22-24, 2023, in Berlin, Germany. Dr. Kjøller will discuss the current HS landscape incl. learnings on new ways to develop better treatments across dermatology and immunology.   Dr. Kjøller will also be

Sales of Kemppi welding gloves started

KEMPPI     PRESS RELEASE     10 MAY 2023     09.00 EET Sales of Kemppi welding gloves started Kemppi welding gloves, now available for ordering, keep welding hands safe. Kemppi welding gloves have been developed with Kemppi’s uncompromising design integrity and safety standards, with high-quality materials for excellent functionality. Welding gloves fulfills Kemppi’s safety offering. “It simply felt like a logical next step in our product development – since we know welding, we had a good sense of what is required from a pair of truly great welding gloves,” says Roger Rasmussen,

Interim report

January 1 – March 31, 2022The first quarter in figures · Net sales were TSEK 5,149 (4,260), +21%. · The loss after tax was TSEK 10,906 (9,736). · The loss per share was SEK 0.15 (0.14). · The cash flow from current operations was negative in the amount of TSEK 3,751 (10,512). · The gross margin was 68.7% (62.8%). · Electrode sales volume increased by 16% and were 11,614 (9,982) units. Repeat sales of electrodes to existing customers increased by 11%. Important events during the quarter · Overall sales increased by 21% (+13%, before currency effects). Sales in the

Photocure ASA: Results for the first quarter of 2023

Oslo, Norway, 10 May 2023 - Photocure ASA (OSE:PHO) today reported Hexvix[®]/Cysview[®] revenues of NOK 105.9 million in the first quarter of 2023 (Q1 2022: NOK 81.4 million) and EBITDA of minus NOK 1.2 million (NOK -13.9 million). Total revenues increased 30% year over year, and 30 high-definition blue light towers were installed in the first quarter (18 new and 12 upgrades). Photocure reiterates its guidance for 2023 and expects to deliver new Saphira™ blue light tower installations in the U.S. in the range of 65 to 75, consolidated product revenue growth above 20%, and positive EBITDA

Nordic Mining ASA (EN Expand:NOM): Interim report per 31 March 2023

Please find enclosed Nordic Mining’s interim report and company presentation for the first quarter of 2023. The interim report and company updates will be presented digitally today, Wednesday 10 May 2023 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230510_6 Summary of important events in the first quarter of 2023 and year to date: KEY EVENTS ·

2020 Bulkers Ltd. (2020) - Results for the first quarter of 2023

Oslo, Norway, May 10, 2023 2020 Bulkers Ltd. (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three months ended March 31, 2023. Key events during the first quarter of 2023 · The Company reported net profit of US$0.8 million and EBITDA of US$6.4 million for the first quarter of 2023. · Achieved average time charter equivalent earnings of approximately US$17,500 per day, gross. · The Company declared total cash distributions of US$0.04 per share for the months of January, February and March 2023. · In January

MTG concludes SEK 377 million share buy-back program

Modern Times Group MTG AB (publ) (“MTG”) has today successfully concluded the share repurchase program launched in October 2022, which has enabled MTG to buy back 4,618,588 own class B shares for approximately SEK 377,4 million, at a volume-weighted average price of SEK 81.7145 per share. This initiative is part of MTG’s ongoing efforts to optimize its capital structure and deliver shareholder value.MTG has created significant shareholder returns since the divestment of ESL Gaming in April 2022. This has been achieved through a cash transfer of SEK 25 per share through MTG’s SEK 2.8 billion

FlexQubes report for the first quarter 2023

FIRST QUARTER 2023 · Order intake decreased by 25.6 percent to 35.7 MSEK (48.0). Adjusted for foreign exchange rate effects between the comparison periods, order intake decreased by 34.6 percent.  · Net sales decreased by 32.5 percent to 29.4 MSEK (43.5). Adjusted for foreign exchange rate effects between the comparison periods, net sales decreased by 37.0 percent. · Operating profit before depreciation (EBITDA) amounted to -11.9 MSEK (-4.8) and operating profit before financial items (EBIT) amounted to -13.3 MSEK (-6.0). · Profit before tax amounted to -13.7 MSEK (-6.1). ·

Orthex’s Q1 Interim Report and invitation to the result presentation on 17 May 2023

Orthex Corporation, Press release, 10 May 2023 at 9.00 a.m. EESTOrthex will publish its Interim Report for the period January−March 2023 on Wednesday, 17 May 2023 at around 9.00 a.m. EEST. Following the publication, the report will be available in pdf-format on the corporate website https://investors.orthexgroup.com/.Orthex’s CEO Alexander Rosenlew, CFO Saara Mäkelä and CMO Hanna Kukkonen will present the interim report on the same day at 11.00 a.m. EEST in a webcast. The webcast can be joined through this link . The webcast presentation

Polymer Factory Sweden AB (publ) Interim Report Q1 2023

The period in summary First quarter, January-March 2023 · Net sales increased with close to 40% compared to the same period 2022 · The Board of Directors resolved on a share issue, with subsequent approval by the EGM · The Company raised approx. SEK 6,1 million* through a rights issue of shares · The first instalment of the EDF grant was paid, amounting to approx. SEK 1,8 million *before deduction of transaction related costs Key Figures (KSEK) Jan-Mar Jan-Mar 2023 2022Net sales

There are no items matching the current filter
There are no more items matching the current filter
Back to top